Apotex Challenges FDA “Shared” Generic Exclusivity Policy In Paxil Suit

TorPharm is challenging FDA's policy of awarding "shared" 180-day marketing exclusivity to multiple generic companies

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet